Acxion 30mg Pills ( Buy Phentermine )

Description

What are Acxion 30mg Pills?

Acxion 30mg is used for the treatment of obesity and weight loss. It contains phentermine, which is an appetite suppressant and central nervous system stimulant medication. It helps reduce appetite, increases the feeling of satiety and promotes weight loss in people who are overweight or who have difficulty controlling their appetite. However, it is important to highlight that Acxion Phentermine 30 mg must be used under the supervision and prescription of a doctor, since it is a medication with possible side effects and contraindications.

• Patient > 18 years old. From 15 mg to 30 mg per day, 30 to 50 mins. before food, take it in the morning.

• Box with 30 15 mg tablets
• Box with 30 30 mg tablets

Dosage and administration:

Oral. It is recommended to start therapy with the lowest possible dosage (a dose between 15 mg and 30 mg per day), administered 30 to 50 minutes before food and taken in the morning.

To continue or discontinue its use, you must take into account the following factors:

– The maximum time of use for this therapy will be 36 weeks.

– Stop administration when the patient stops losing weight.

– Discontinue administration if weight loss in 3 months is less than or equal to 5% of the patient’s total body weight.

Considering that prolonged use can induce dependence with withdrawal syndrome on sudden interruption of therapy; To discontinue treatment, the dose should be reduced gradually until discontinuation. The reduction of the medication should be carried out in the following way: the first week three doses, the second week two doses and the following two weeks one dose.

Do not administer IFA Fentermina to children under 18 years of age or the elderly.

In patients using treatment with sympathomimetics for the first time, it is important to evaluate the response to treatment in terms of tolerance and safety, so it is advisable to perform an evaluation 10 days after starting treatment. Subsequently, medical evaluations of efficacy and safety must be made at least monthly during the time of treatment.